Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Optimal strategies for the management of antiplatelet and anticoagulation medications prior to cardiac device implantation Tompkins C; Henrikson CACardiol J 2011[]; 18 (1): 103-9Choosing the optimal management strategy for antiplatelet and anticoagulation medications at the time of cardiac device implantation can be challenging. Simply withholding or reversing these medications puts patients at risk of subsequent thromboembolic events. Equally, continuing these medications may unnecessarily increase the risk of bleeding complications. This article summarizes recent findings and provides compelling evidence challenging current recommendations outlined by various professional organizations.|*Defibrillators, Implantable[MESH]|*Pacemaker, Artificial[MESH]|Anticoagulants/*administration & dosage/adverse effects[MESH]|Cardiac Surgical Procedures/adverse effects/*instrumentation[MESH]|Drug Administration Schedule[MESH]|Evidence-Based Medicine[MESH]|Hemorrhage/chemically induced[MESH]|Humans[MESH]|Perioperative Care[MESH]|Platelet Aggregation Inhibitors/*administration & dosage/adverse effects[MESH]|Practice Guidelines as Topic[MESH]|Thromboembolism/*prevention & control[MESH] |
